Nancy Brown Archives
Jun. 15, 2017—Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine in the Vanderbilt University School of Medicine, shared a bumper crop of good news in her annual State of the Department address last week.
Mar. 16, 2017—Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).
Jan. 5, 2017—Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the school’s Department of Medicine, which, during the 2016 federal fiscal year that ended Sept. 30, broke another record.
Jun. 9, 2016—Nancy Brown, M.D., chair of the Department of Medicine, ticked off a wealth of accomplishments for the 2016 academic year at the recent State of the Department of Medicine Address
Nov. 18, 2015—The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported. Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increased blood flow. Sildenafil is used to treat erectile dysfunction and pulmonary arterial...
Sep. 17, 2015—Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.
Oct. 21, 2014— Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization announced this week. With more than 1,900 active members and foreign associates, the IOM...
Jul. 25, 2013—High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.
Jun. 13, 2013—Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.